VOLITIONRX LTD 8-K

What Happened
VolitionRx Ltd (VNRX) filed an 8-K reporting that its board approved and the company effected a 1-for-20 reverse stock split of its common stock. Stockholders had authorized the board at a special meeting on March 31, 2026 to implement a reverse split within an approved range; the board selected a one-for-twenty ratio. The company filed a Certificate of Third Amendment to its Second Amended and Restated Certificate of Incorporation with the Delaware Secretary of State on April 27, 2026, which became effective at 12:01 a.m. ET on April 28, 2026.

Key Details

• Special stockholder meeting held March 31, 2026 granted the board authority to implement a reverse stock split within an approved range.
• Board approved a reverse split at a ratio of 1-for-20.
• Certificate of Third Amendment filed April 27, 2026 and effective April 28, 2026 at 12:01 a.m. ET.
• The amendment also describes the treatment of any fractional shares resulting from the reverse split. The filing notes a material modification to the rights of security holders in connection with this action.

Why It Matters
A reverse stock split reduces the number of outstanding shares and proportionally increases the per-share price while generally leaving the company’s total equity value unchanged. For investors, this means individual share counts will be consolidated (every 20 shares become 1), and brokerage accounts will be adjusted according to the amendment’s fractional-share treatment. Shareholders should watch for communications from VolitionRx and their brokers about how the split and any fractional-share cash-out or adjustments will be handled.